Position in RYTM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,340,909
+$443,553 QoQ
Shares Held
12,077
+17.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#149
of 299 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Entropy Technologies, LP holds $54,448,699 across 47 Biotechnology names. RYTM ranks #10 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
41,204 | $12,403,640 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,606 | $5,989,725 | |
| 3 | INSM |
INSMED Inc
|
45,469 | $4,847,904 | |
| 4 | RPRX |
Royalty Pharma plc
|
58,767 | $3,295,065 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
36,815 | $2,919,061 | |
| 6 | EXEL |
Exelixis, Inc.
|
52,488 | $2,855,872 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
27,148 | $2,021,983 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
24,583 | $1,547,254 |
All Filings in RYTM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,340,909 | 12,077 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $897,356 | 10,318 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $266,743 | 2,492 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $858,616 | 8,502 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $291,440 | 5,502 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||